跳至主要内容
临床试验/CTRI/2021/01/030610
CTRI/2021/01/030610招募中3 期

Once daily vs twice daily dose of low molecular weight heparin in treatment of severe acute pancreatitis: A randomized, controlled, open-label, pilot study

ILBS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
ILBS

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All adult cases of severe acute pancreatitis , who do not match exclusion criteria ,admitted to ILBS during study period will be included in the study .

排除标准

  • Patients with:
  • -chronic pancreatitis.
  • -hypersensitivity to LMWH
  • -Pregnant or breast feeding ladies
  • - pediatric age group
  • - prior coagulopathy.
  • - CLD with acute pancreatitis.
  • - Stroke/ CVA(Cerebro-Vascular Accident)
  • - Established SP axis thrombus
  • - Presentation beyond 10 days from onset of pancreatitis

研究者

发起方
ILBS

相似试验